Hong Kong stock anomaly | Keji Pharmaceutical-B (02171.HK) rose by more than 6%. The research results of Kailimei will be presented in a poster at the 2026 ESMO Annual Meeting.

According to the Chinese financial news app Zhi Tong Finance, Keji Pharmaceuticals - B (02171.HK) has risen more than 6%, as of the time of publication, it has increased by 5.94%, to 16.42 Hong Kong dollars, with a trading volume of 32.6285 million Hong Kong dollars.